Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
R., Wu, J., Gigliotti, J
Transparent operations: We evaluate how transparent and straightforward a clinics operations, pricing, and marketing are
From the perspective of a blood donation center, the active ingredient is what matters most
PMID: 29915025 Kurutas, E.B
These events were generally mild to moderate in severity and included: Nausea often accompanying changes in bowel habits, particularly after dose escalation Diarrhoea loose or watery stools, sometimes with urgency Vomiting less common but reported, especially at higher doses Constipation occurring in some individuals, reflecting the variable effect on gut motility Abdominal discomfort or bloating a sensation of fullness or cramping Flatulence increased wind, which can accompany altered digestion Gastrointestinal adverse events were the most common reason for discontinuation in the Phase 2 trial, occurring in approximately 510% of participants depending on dose group
US$ 23.00
US$ 20.85
US$ 22.05
US$ 28.38
